(Reuters) - Akzo Nobel said on March 12 it would sell its pharma unit Organon BioSciences for $14 billion to U.S. drug giant Schering-Plough Corp , surprising investors who expected details of an initial public offering .
First-quarter net profit including the pharma unit fell 1 percent to 246 million euros. The average analyst expectation was 211 million euros.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment